Search the Newsreel

Samsung Securities Co., Ltd. Revenue Breakdown – KRX:016360

Samsung and SK Hynix Plunge as China Chip Fears Intensify

This article first appeared on GuruFocus. Samsung Electronics (SSNLF), a major South Korean memory-chip producer, fell 13.4% on Tuesday, while SK Hynix (HXSCL), a leading supplier of high-bandwidth memory chips used in AI systems, dropped 14.7%. Samsung recorded its worst one-day decline in almost …

Samsung Card Co., Ltd Revenue Breakdown – KRX:029780

KOSPI Dragged Down 11% by SK Hynix, Samsung as China Chip Fears Spread

The world’s hottest major index dived almost 11% as fears about cheap Chinese chip competition bled into international markets after ravaging U.S. tech stocks. Continue Reading

Broadcom (AVGO) Lands $200 Billion Samsung AI Chip Deal Through 2030

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Samsung and Broadcom (NasdaqGS:AVGO) agreed a more than US$200b AI semiconductor deal running through 2030. The agreement focuses on next generation AI infrastructure, advanced …

Why a Slump in South Korean Stocks Has the U.S. Market on Edge

South Korean stocks got hammered on Tuesday, and that's a major worry for Wall Street. The country's flagship Kospi index plunged more than 10%, dragged down by slumps in the shares of memory-chip makers SK Hynix and Samsung. Continue Reading

Update: Gossamer Bio Extends Gains Pre-Bell Following New Drug Application Filing Plans for Pulmonary Arterial Hypertension Treatment

Gossamer Bio's stock showed significant pre-bell gains after the company announced its plans to file a New Drug Application (NDA) for its pulmonary arterial hypertension (PAH) treatment, seralutinib. This positive market response follows encouraging trial results for the drug. The company expects to submit …

Leerink upgrades Gossamer Bio stock rating on FDA feedback

Leerink upgraded Gossamer Bio Inc. (NASDAQ:GOSS) to Outperform from Market Perform, raising its price target to $1.00 following positive FDA feedback on the company's PROSERA trial. The FDA's assessment of the trial's statistical significance as a review issue rather than a filing issue reduced …

Stock market today: S&P 500, Nasdaq futures slide as chip sell-off deepens

US tech stocks sank before the bell on Tuesday as a sell-off in Korean memory makers underscored concerns about AI circular financing deals, overshadowing a drop in oil prices and earnings optimism. Contracts on the Nasdaq-100 (NQ=F) fell 0.9%, signaling further losses for the …

Is The Boston Beer Company (SAM) Stock a Buy as Margin Gains Offset Ongoing Volume Declines?

Samsara Inc. (IOT) Just Reclaimed the 50-Day Moving Average

Gossamer Bio (GOSS) Projected to Release Quarterly Earnings on Tuesday

DB Securities cuts Samsung Card target as Korea rate hikes lift funding costs - CHOSUNBIZ

Sambhaav Media sends physical AGM links to unregistered shareholders

Samuel Heath reports flat revenue, lower profit for fiscal 2026 By Investing.com

ETFs Investing in Boston Beer Company, Inc. Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Boston Beer Company, Inc. Class A (BBEA) stocks, providing crucial investment data for each. It details metrics such as market value, weight of BBEA in the fund, issuer, management style, expense ratio, AUM, price, …

Asian shares slip and South Korea’s Kospi index sinks 10% on heavy selling of chipmaking stocks

HONG KONG (AP) — South Korea's Kospi index plunged more than 10% on Tuesday on heavy selling of chipmaking stocks that have gyrated recently due to concerns over the sustainability of the boom in artificial intelligence. Oil prices fell more than 1%, while U.S. …

Leerink Partners Upgrades Gossamer Bio(GOSS.US) to Buy Rating, Cuts Target Price to $1

Leerink Partners has upgraded its rating for Gossamer Bio (GOSS.US) to "Buy." Despite the upgrade, the target price for the stock has been reduced to $1.

Samsung, SK Hynix slide amid Nvidia financing worries, China competition

By Heekyong Yang SEOUL, July 28 (Reuters) - South Korean chip stocks slumped on Tuesday, with Samsung Electronics and SK Hynix falling as much as ‌9.5% and 10.9%, respectively, as investors dumped AI-related bets amid mounting concerns ‌over financing risks tied to AI infrastructure …

Gossamer Bio Inc (GOSS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Gossamer Bio Inc (GOSS), detailing its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 6.30 and is trading within a range suitable …

How South Korea’s Leveraged ETF Gambit Backfired

Korean stocks have been wildly volatile in recent months–and leveraged ETFs deserve some of the blame. SK Hynix and Samsung have emerged as major beneficiaries of the AI-driven memory chip shortage, leading to meteoric rises. Korean regulators approved single-stock leveraged ETFs for SK Hynix …

12 Health Care Stocks Moving In Monday's After-Market Session

This article lists 12 healthcare stocks that experienced significant movement in Monday's after-market session, highlighting both gainers and losers. Notable gainers include Gossamer Bio, ProMIS Neurosciences, OPKO Health, OrthoPediatrics, Matinas BioPharma Hldgs, and Olema Pharmaceuticals. Conversely, Radiopharm Theranostics, Redhill Biopharma, HeartSciences, iBio, Cumberland Pharma, …

Gossamer Reacquires Global Seralutinib Rights From Chiesi, Receives $5 Million

Gossamer Bio has reacquired the global development and commercial rights for seralutinib from Chiesi, terminating their 2024 Collaboration and License Agreement. Chiesi will pay Gossamer $5 million for development costs, while Gossamer will pay success-based milestones and royalties to Chiesi. This move returns key …

Broadcom Stock Jumps as Samsung Lands Massive $200 Billion AI Chip Deal

This article first appeared on GuruFocus. Broadcom (NASDAQ:AVGO) shares climbed about 3% on Monday after Samsung Electronics (SSNLF) signed a memorandum of understanding to provide the company with memory and foundry chips through 2030 under an agreement valued at more than $200 billion. The …

Gossamer Sets September NDA Filing For Seralutinib In Pulmonary Arterial Hypertension; Stock Up

(RTTNews) - Gossamer Bio, Inc. (GOSS) announced that following a productive Pre-NDA Type B meeting with the U.S. FDA and receipt of the official meeting minutes, the company is moving forward with a planned NDA submission for Seralutinib in pulmonary arterial hypertension in September …

Samfine Creation Holdings Group Ltd (SFHG) Balance Sheet

This article provides the balance sheet for Samfine Creation Holdings Group Ltd (SFHG), detailing its quarterly and annual financial data. It covers key financial metrics including total equity, cash and cash equivalents, receivables, inventory, assets, liabilities, and shareholders' equity. The information is presented to …

China Memory Giant CXMT Becomes a Top Holding in Tema Memory ETF (DISK)

DISK offers highest exposure to CXMT of any U.S.-listed ETF. NEW YORK, July 27, 2026--(BUSINESS WIRE)--Tema ETFs ("Tema"), a leader in institutional-quality and actively managed exchange-traded funds, today announced that ChangXin Memory Technologies (CXMT) has been added to the Tema Memory ETF (DISK) as …

EXCLUSIVE: China Is Coming For SanDisk—But Not Yet For Micron’s Memory Crown

High-bandwidth memory — the specialized chips powering Nvidia Corp.'s latest AI accelerators — appears set to remain dominated by established leaders such as Micron Technology Inc. (NASDAQ:MU), SK Hynix Inc.(NASDAQ:SKHY) and Samsung Electronics Co. Ltd. (NYSE:SSNLF) for years. China, however, is making rapid progress …

Broadcom and Samsung’s Expanded Pact Could Unleash $1 Trillion Revenue Wave

Broadcom will receive the bulk of its memory needs from Samsung through 2030, according to J.P. Morgan. Continue Reading

Gossamer Bio shares jump after FDA update and seralutinib rights return

Gossamer Bio (NASDAQ:GOSS) shares surged 25% following a positive FDA regulatory update for its lead drug candidate, seralutinib, and the regaining of full global rights to the therapy. The company anticipates submitting a New Drug Application (NDA) for seralutinib in pulmonary arterial hypertension (PAH) …

Samsara EVP, CTO John Bicket sells $9.5m in stock in July

Samsara Inc.'s EVP, CTO, and Director John Bicket sold 262,900 shares of Class A Common Stock for approximately $9.5 million on July 21 and 22, 2026, under Rule 10b5-1 trading plans. These sales occurred during a challenging week for the stock, which declined nearly …

Gossamer Bio stock surges 25% on FDA regulatory update

Gossamer Bio Inc. (NASDAQ:GOSS) shares surged 25% after the company announced a regulatory update from the FDA regarding its drug seralutinib for pulmonary arterial hypertension (PAH) and reacquired worldwide rights to the drug. The company plans to submit a New Drug Application (NDA) for …

Broadcom’s Expanded Samsung Pact Shows AI Trade Is Still All About Memory

Broadcom will receive the bulk of its memory needs from Samsung through 2030, according to J.P. Morgan. Continue Reading

Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?

Investing.com -- Bernstein has reiterated its bullish stance on memory chipmakers following a wave of multibillion-dollar partnerships announced at an AI Summit hosted by the South Korean government in San Francisco on Friday, where Samsung, SK Hynix, Nvidia and Broadcom unveiled new agreements spanning …

Samfine Creation Holdings Group Ltd

This article provides a revenue breakdown for Samfine Creation Holdings Group Ltd (SFHG), detailing its business segments and regional revenue contributions. For FY2024, the company generated revenue from book products and novelty and packaging products, with all revenue originating from the PRC. It also …

[Click e-Stock] "Samsung Epis Holdings: Focus on New Drug Development Strategy Over Short-Term Earnings... Target Price Lowered"